TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF SPINAL STENOSIS AND NEUROLOGICAL DISORDERS

4.2.2 RISING GERIATRIC POPULATION PRONE TO SPINAL DISORDERS

4.2.3 INCREASING APPLICATION OF SPINAL NEEDLES FOR SPINE SURGERIES

4.3 RESTRAINTS

4.3.1 SIDE EFFECTS AND COMPLICATIONS ASSOCIATED WITH SPINE SURGERY

4.3.2 STRINGENT GOVERNMENT REGULATIONS

4.4 OPPORTUNITIES

4.4.1 INCREASING NUMBER OF COLLABORATIONS, ACQUISITIONS, AND PRODUCT LAUNCHES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D AND DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION, MARKETING, & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 COVID-19 IMPACT ANALYSIS

5.3.1 IMPACT ON SPINAL SURGERY

5.3.2 IMPACT ON SPINE SURGEONS

5.3.3 IMPACT ON CLINICAL TRIALS

6 GLOAL SPINAL NEEDLES MARKET, BY TYPE

6.1 INTRODUCTION

6.2 ATRAUMATIC NEEDLES

6.3 DIRECTIONAL SPINAL NEEDLES

6.4 PENCIL-POINT NEEDLES

7 GLOBAL SPINAL NEEDLES MARKET, BY APPLICATION

7.1 INTRODUCTION

7.2 THERAPEUTIC

7.3 DIAGNOSTIC

8 SPINAL NEEDLES MARKET, BY END USER

8.1 OVERVIEW

8.2 HOSPITALS & CLINICS

8.3 DIAGNOSTIC CENTERS

8.4 RESEARCH LABORATORIES

8.5 SPECIALTY CENTERS

9 GLOBAL SPINAL NEEDLES MARKET, BY REGION

9.1 OVERVIEW

9.2 AMERICAS

9.2.1 NORTH AMERICA

9.2.1.1 US

9.2.1.2 CANADA

9.2.2 LATIN AMERICA

9.3 EUROPE

9.3.1 WESTERN EUROPE

9.3.1.1 GERMANY

9.3.1.2 FRANCE

9.3.1.3 UK

9.3.1.4 ITALY

9.3.1.5 SPAIN

9.3.1.6 REST OF WESTERN EUROPE

9.3.2 EASTERN EUROPE

9.4 ASIA PACIFIC

9.4.1 CHINA

9.4.2 INDIA

9.4.3 JAPAN

9.4.4 SOUTH KOREA

9.4.5 AUSTRALIA

9.4.6 REST OF ASIA PACIFIC

9.5 MIDDLE EAST & AFRICA

9.5.1 MIDDLE EAST

9.5.2 AFRICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL SPINAL NEEDLES MARKET

10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL SPINAL NEEDLES MARKET

10.5 KEY DEVELOPMENT ANALYSIS

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

10.6.2 MERGER/ACQUISITION

10.6.3 EXPANSION/INVESTMENT

10.7 FINANCIAL MATRIX

10.7.1 SALES (USD MILLION) AND OPERATING PROFIT MARGIN (%), 2020

10.7.2 R&D EXPENDITURE (USD MILLION), 2020

11 COMPANY PROFILES

11.1 STRYKER CORPORATION

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 BOSTON SCIENTIFIC CORPORATION

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS/SERVICES OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 B. BRAUN MELSUNGEN AG

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS/SERVICES OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 MEDTRONIC PLC

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS/SERVICES OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.4.6 KEY STRATEGIES

11.5 SMITHS MEDICAL

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS/SERVICES OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 SWOT ANALYSIS

11.5.6 KEY STRATEGIES

11.6 BECTON, DICKINSON, AND COMPANY

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 SWOT ANALYSIS

11.6.6 KEY STRATEGIES

11.7 EXELINT INTERNATIONAL, CO.

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 SWOT ANALYSIS

11.7.6 KEY STRATEGIES

11.8 ARGON MEDICAL

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.8.6 KEY STRATEGIES

11.9 MYCO MEDICAL

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 SWOT ANALYSIS

11.9.6 KEY STRATEGIES

11.10 COOK MEDICAL

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 SWOT ANALYSIS

11.10.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS